Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Certified by Founder
Lodge
ArkeaBio™
start up
United States
- Charlestown, Massachusetts
- 10/05/2024
- Series A
- $26,500,000
ArkeaBioTM is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices.
- Industry Biotechnology Research
- Website https://www.arkeabio.com/
- LinkedIn https://www.linkedin.com/company/arkeabio/
Related People
Colin SouthFounder
United States -
Boston, Massachusetts
Experience leading dynamic, technically intense organizations in the Food, Life Sciences, and Energy sectors. Extensive engineering and science training and experience combined with management and technology leadership roles. Experience in high-profile executive roles with world-class teams to execute high-stakes management decisions. Business focus in complex roles; defining value capture strategies, establishing pathways to commercialization and overcoming complex business obstacles.
Fleetzero | $43,000,000 | (Jan 20, 2026)
EXCIVA GmbH | $59,817,135 | (Jan 20, 2026)
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
one • fıve | $16,320,500 | (Jan 20, 2026)
Anzen Industries | $2,283,975 | (Jan 20, 2026)
Dominion Dynamics | $15,200,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
RouteSense | $2,000,000 | (Jan 16, 2026)